[Nitrofurantoin induced hypersensitivity reactions in the lungs]. 1976

A R Sovijärvi, and M Lemola, and B Stenius, and E Taskinen, and P Tukiainen, and J Idänpään-Heikkilä

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008171 Lung Diseases Pathological processes involving any part of the LUNG. Pulmonary Diseases,Disease, Pulmonary,Diseases, Pulmonary,Pulmonary Disease,Disease, Lung,Diseases, Lung,Lung Disease
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009582 Nitrofurantoin A urinary anti-infective agent effective against most gram-positive and gram-negative organisms. Although sulfonamides and antibiotics are usually the agents of choice for urinary tract infections, nitrofurantoin is widely used for prophylaxis and long-term suppression. Furadantin,Furadantine,Furadoine,Furadonine,Furantoin,Macrodantin,Nitrofurantoin Sodium Salt,Nitrofurantoin, Monohydrate
D011658 Pulmonary Fibrosis A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death. Alveolitis, Fibrosing,Idiopathic Diffuse Interstitial Pulmonary Fibrosis,Fibroses, Pulmonary,Fibrosis, Pulmonary,Pulmonary Fibroses,Alveolitides, Fibrosing,Fibrosing Alveolitides,Fibrosing Alveolitis
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children

Related Publications

A R Sovijärvi, and M Lemola, and B Stenius, and E Taskinen, and P Tukiainen, and J Idänpään-Heikkilä
June 1970, Helvetica medica acta. Supplementum,
A R Sovijärvi, and M Lemola, and B Stenius, and E Taskinen, and P Tukiainen, and J Idänpään-Heikkilä
December 1970, Schweizerische medizinische Wochenschrift,
A R Sovijärvi, and M Lemola, and B Stenius, and E Taskinen, and P Tukiainen, and J Idänpään-Heikkilä
July 1970, The Medical journal of Australia,
A R Sovijärvi, and M Lemola, and B Stenius, and E Taskinen, and P Tukiainen, and J Idänpään-Heikkilä
February 1972, Singapore medical journal,
A R Sovijärvi, and M Lemola, and B Stenius, and E Taskinen, and P Tukiainen, and J Idänpään-Heikkilä
November 1973, The Journal of urology,
A R Sovijärvi, and M Lemola, and B Stenius, and E Taskinen, and P Tukiainen, and J Idänpään-Heikkilä
June 2001, The Medical journal of Australia,
A R Sovijärvi, and M Lemola, and B Stenius, and E Taskinen, and P Tukiainen, and J Idänpään-Heikkilä
September 1987, Clinical pharmacy,
A R Sovijärvi, and M Lemola, and B Stenius, and E Taskinen, and P Tukiainen, and J Idänpään-Heikkilä
September 2005, Oncology nursing forum,
A R Sovijärvi, and M Lemola, and B Stenius, and E Taskinen, and P Tukiainen, and J Idänpään-Heikkilä
November 2002, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
A R Sovijärvi, and M Lemola, and B Stenius, and E Taskinen, and P Tukiainen, and J Idänpään-Heikkilä
October 1984, Drug intelligence & clinical pharmacy,
Copied contents to your clipboard!